Related Experiment Videos
2. Advances in pharmacotherapy for COPD
1The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Wakayama. masakazu@wakayama-med.ac.jp
Insights
Chronic obstructive pulmonary disease (COPD) is a growing global health issue. This review outlines current pharmacological therapy recommendations for stable COPD based on global and Japanese guidelines to address underdiagnosis and undertreatment.
Area of Science:
- Pulmonology
- Internal Medicine
- Public Health
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading global cause of death and disease burden.
- COPD prevalence and impact are increasing worldwide, yet research investment remains low.
- Recent global and Japanese guidelines aim to improve COPD diagnosis and treatment.
Purpose of the Study:
- To review current pharmacological therapy recommendations for stable COPD.
- To align with recent global and Japanese COPD management guidelines.
- To address the underdiagnosis and undertreatment of COPD.
Main Methods:
- Literature review of global and Japanese COPD guidelines.
- Synthesis of current evidence on pharmacological treatments for stable COPD.
- Analysis of guideline recommendations for managing stable COPD.
Main Results:
- Guidelines provide updated recommendations for stable COPD pharmacological therapy.
- Specific treatments are suggested to manage symptoms and reduce exacerbations.
- Emphasis on individualized treatment approaches based on disease severity.
Conclusions:
- Current guidelines offer a framework for effective COPD management.
- Pharmacological therapies are crucial for improving patient outcomes.
- Adherence to guidelines can mitigate the growing burden of COPD.
Abstract:
Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Inhaled Medications
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...